Uniunea Europeană - română - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - pui - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.

Uniunea Europeană - română - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease (md) virus, serotype 1, strain rn1250 - imunologii pentru aves - pui - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus).

Uniunea Europeană - română - EMA (European Medicines Agency)

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - imunologii pentru aves - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).

Uniunea Europeană - română - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - imunologii pentru aves - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Uniunea Europeană - română - EMA (European Medicines Agency)

intervet international b.v. - celule asociate viu recombinant turcia herpesvirus (tulpina hvp360), exprimarea proteinei de fuziune a nd virus și vp2 proteine de ibd virus - aviare, virusul herpes (marek boala lui) + virusul bursitei infecțioase aviare (boala de gumboro) + virusul bolii de newcastle/paramixovirus - chicken; embryonated chicken eggs - for active immunisation of one-day-old chicks or 18-19-day-old embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to prevent mortality and to reduce clinical signs and lesions caused by infectious bursal disease (ibd) virus,to reduce mortality, clinical signs and lesions caused by marek’s disease (md) virus.

Uniunea Europeană - română - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - pui - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.

Uniunea Europeană - română - EMA (European Medicines Agency)

sanofi pasteur - chimeric yellow fever dengue virus serotype 1 (live, attenuated), chimeric yellow fever dengue virus serotype 2 (live, attenuated), chimeric yellow fever dengue virus serotype 3 (live, attenuated), chimeric yellow fever dengue virus serotype 4 (live, attenuated) - dengue - vaccinuri - dengvaxia is indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4 in individuals 6 to 45 years of age with test-confirmed previous dengue infection (see sections 4. 2, 4. 4 și 4. utilizarea de dengvaxia ar trebui să fie în conformitate cu recomandările oficiale.

Uniunea Europeană - română - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - pui - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.

Uniunea Europeană - română - EMA (European Medicines Agency)

virbac s.a. - purified p45 feline leukaemia virus envelope antigen, live feline calicivirus (strain f9), live feline viral rhinotracheitis virus (strain f2), live feline panleucopenia virus - live virusului panleucopeniei feline / parvovirus + live virusul rinotraheitei feline + live calicivirus felin + inactivat virusul leucemiei feline - pisici - pentru imunizarea activă a pisicilor de la opt săptămâni împotriva: calicivirozei feline pentru a reduce semnele clinice. feline rinotraheita virală pentru a reduce semnele clinice și excreția virale. feline panleucopenia pentru a preveni leucopenia și pentru a reduce semnele clinice. leucemie felină pentru a preveni viremia persistentă și semne clinice ale bolii asociate. debutul imunității: 3 săptămâni după vaccinarea primară pentru panleucopeniei și leucemie componente, și la 4 săptămâni după vaccinarea primară pentru calicivirus și virusul rinotraheitei componente. durata imunității: la un an după vaccinarea primară pentru toate componentele.

Uniunea Europeană - română - EMA (European Medicines Agency)

laboratorios hipra s.a - live ge-tk- virusul herpetic bovin dublu-deletat de tip 1, tulpina ceddel: 106,3-107,3 ​​ccid50 - immunologicals - bovine - pentru imunizarea activă a bovinelor de la trei luni împotriva bovine herpes virus tip 1 (bohv-1) pentru a reduce semnele clinice ale rinotraheitei infecțioase bovine (ibr) și a excreției de virus. debutul imunității: 21 de zile de la finalizarea schemei de vaccinare de bază. durata imunității: 6 luni de la terminarea schemei de vaccinare de bază.